
AstraZeneca PLC ADRhedged (AZNH) Stock Overview
Explore AstraZeneca PLC ADRhedged’s financial performance, market position, analyst ratings, and future outlook.
AstraZeneca PLC ADRhedged (AZNH)
Key Financials
Key Financials
Market Cap
1.6M
P/E Ratio
N/A
EPS (TTM)
$1.40
ROE
0.00%
AZNH Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of AstraZeneca PLC ADRhedged (AMEX: AZNH) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, AstraZeneca PLC ADRhedged's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of AZNH on the AMEX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $75.09 for the AMEX listing.
Key metrics behind AstraZeneca PLC ADRhedged's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 1.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AZNH on the AMEX.